Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 135
  2. 136
  3. 137
  4. 138
  5. 139
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Vilobelimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5285-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Vilobelimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5285-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Vilobelimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5285-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Visugromab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5286-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Visugromab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5286-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Visugromab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5286-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Visugromab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5286-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Visugromab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5286-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Volociximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5287-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Volociximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5287-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Volociximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5287-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Volociximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5287-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Volociximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5287-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Vonsetamig Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5288-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Vonsetamig Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5288-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Vonsetamig Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5288-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Vonsetamig Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5288-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Vonsetamig Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5288-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Xeligekimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5289-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Xeligekimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5289-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Xeligekimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5289-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Xeligekimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5289-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Xeligekimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5289-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Zansecimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5290-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Zansecimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5290-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Name Preis
Vilobelimab Biosimilar -­ Research Grade Anmelden Vilobelimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Vilobelimab Biosimilar -­ Research Grade Anmelden Vilobelimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Vilobelimab Biosimilar -­ Research Grade Anmelden Vilobelimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Visugromab Biosimilar -­ Research Grade Anmelden Visugromab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Visugromab Biosimilar -­ Research Grade Anmelden Visugromab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Visugromab Biosimilar -­ Research Grade Anmelden Visugromab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Visugromab Biosimilar -­ Research Grade Anmelden Visugromab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Visugromab Biosimilar -­ Research Grade Anmelden Visugromab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Volociximab Biosimilar -­ Research Grade Anmelden Volociximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Volociximab Biosimilar -­ Research Grade Anmelden Volociximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Volociximab Biosimilar -­ Research Grade Anmelden Volociximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Volociximab Biosimilar -­ Research Grade Anmelden Volociximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Volociximab Biosimilar -­ Research Grade Anmelden Volociximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Vonsetamig Biosimilar -­ Research Grade Anmelden Vonsetamig Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Vonsetamig Biosimilar -­ Research Grade Anmelden Vonsetamig Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Vonsetamig Biosimilar -­ Research Grade Anmelden Vonsetamig Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Vonsetamig Biosimilar -­ Research Grade Anmelden Vonsetamig Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Vonsetamig Biosimilar -­ Research Grade Anmelden Vonsetamig Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Xeligekimab Biosimilar -­ Research Grade Anmelden Xeligekimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Xeligekimab Biosimilar -­ Research Grade Anmelden Xeligekimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Xeligekimab Biosimilar -­ Research Grade Anmelden Xeligekimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Xeligekimab Biosimilar -­ Research Grade Anmelden Xeligekimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Xeligekimab Biosimilar -­ Research Grade Anmelden Xeligekimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Zansecimab Biosimilar -­ Research Grade Anmelden Zansecimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Zansecimab Biosimilar -­ Research Grade Anmelden Zansecimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 135
  2. 136
  3. 137
  4. 138
  5. 139
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top